Handelsbanken Fonder Ab Amgen Inc Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Amgen Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 440,348 shares of AMGN stock, worth $123 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

440,348

Previous 435,990 1.0%

Holding current value

$123 Million

Previous $136 Million 4.15%

% of portfolio

0.56%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$309.38 - $337.38 $1.35 Million - $1.47 Million	4,358 Added 1.0%	440,348 $142 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $5.32 Million - $6.47 Million	20,247 Added 4.87%	435,990 $136 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $12.9 Million - $15.6 Million	48,157 Added 13.1%	415,743 $118 Million
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $979,331 - $1.1 Million	3,830 Added 1.05%	367,586 $106 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $2.31 Million - $2.86 Million	10,545 Added 2.99%	363,756 $97.8 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $11.7 Million - $13.8 Million	-54,382 Reduced 13.34%	353,211 $78.4 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $9.67 Million - $11.8 Million	42,830 Added 11.74%	407,593 $98.5 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $35.9 Million - $45.6 Million	156,582 Added 75.21%	364,763 $95.8 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $7.1 Million - $8.01 Million	31,643 Added 17.92%	208,181 $46.9 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $5.26 Million - $5.85 Million	22,798 Added 14.83%	176,538 $43 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $1.4 Million - $1.55 Million	-6,399 Reduced 4.0%	153,740 $37.2 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $2.74 Million - $3.13 Million	13,772 Added 9.41%	160,139 $36 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $45.4 Million - $53.2 Million	-214,043 Reduced 59.39%	146,367 $31.1 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $3.72 Million - $4.13 Million	-15,933 Reduced 4.23%	360,410 $87.9 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $5.72 Million - $6.66 Million	-25,762 Reduced 6.41%	376,343 $93.6 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $598,507 - $712,715	2,766 Added 0.69%	402,105 $92.5 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $2.81 Million - $3.12 Million	11,969 Added 3.09%	399,339 $101 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $25.8 Million - $31.7 Million	130,642 Added 50.89%	387,370 $91.4 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $5.65 Million - $7.49 Million	31,000 Added 13.73%	256,728 $52 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $5.6 Million - $7.2 Million	29,600 Added 15.09%	225,728 $54.4 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $18.6 Million - $22.3 Million	107,000 Added 120.05%	196,128 $38 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $7.57 Million - $8.87 Million	45,399 Added 103.82%	89,128 $16.4 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $1.09 Million - $1.22 Million	-6,000 Reduced 12.07%	43,729 $8.31 Million
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $519,322 - $606,215	-2,911 Reduced 5.53%	49,729 $9.68 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $9.75 Million - $11 Million	52,640 New	52,640 $10.9 Million
Q3 2018 Oct 19, 2018	SELL	$185.29 - $208.89 $2.77 Million - $3.12 Million	-14,940 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $830,250 - $932,550	-5,000 Reduced 25.08%	14,940 $2.76 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $506,370 - $565,770	-3,000 Reduced 13.08%	19,940 $3.47 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $3.84 Million - $4.38 Million	22,940	22,940 $4.28 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Amgen Inc Transaction History